QSAM Biosciences Statistics
Total Valuation
QSAM has a market cap or net worth of $36.19 million. The enterprise value is $34.81 million.
| Market Cap | 36.19M |
| Enterprise Value | 34.81M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
QSAM has 4.45 million shares outstanding. The number of shares has increased by 78.50% in one year.
| Shares Outstanding | 4.45M |
| Shares Change (YoY) | +78.50% |
| Shares Change (QoQ) | +4.56% |
| Owned by Insiders (%) | 52.36% |
| Owned by Institutions (%) | n/a |
| Float | 2.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 53.82 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.65 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.84 |
Financial Efficiency
Return on equity (ROE) is -741.42% and return on invested capital (ROIC) is -579.91%.
| Return on Equity (ROE) | -741.42% |
| Return on Assets (ROA) | -292.33% |
| Return on Capital (ROIC) | -579.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.25M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, QSAM has paid $721,897 in taxes.
| Income Tax | 721,897 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +60.00% in the last 52 weeks. The beta is 1.81, so QSAM's price volatility has been higher than the market average.
| Beta (1Y) | 1.81 |
| 52-Week Price Change | +60.00% |
| 50-Day Moving Average | 7.12 |
| 200-Day Moving Average | 5.73 |
| Relative Strength Index (RSI) | 71.26 |
| Average Volume (30 Days) | 8,904 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -549,339 |
| Operating Income | -3.94M |
| Pretax Income | -4.39M |
| Net Income | -4.98M |
| EBITDA | -3.94M |
| EBIT | -3.98M |
| Earnings Per Share (EPS) | -$1.79 |
Balance Sheet
The company has $1.39 million in cash and $7,500 in debt, giving a net cash position of $1.38 million or $0.31 per share.
| Cash & Cash Equivalents | 1.39M |
| Total Debt | 7,500 |
| Net Cash | 1.38M |
| Net Cash Per Share | $0.31 |
| Equity / Book Value | 672,348 |
| Book Value Per Share | 0.15 |
| Working Capital | 672,348 |
Cash Flow
| Operating Cash Flow | -2.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.85M |
| FCF Per Share | -$0.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QSAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.50% |
| Shareholder Yield | -78.50% |
| Earnings Yield | -13.78% |
| FCF Yield | -7.87% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 10, 2022. It was a reverse split with a ratio of 1:40.
| Last Split Date | Mar 10, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |